PolyGen Pharmaceuticals, a New York based drug development company, is committed to providing high-quality generic pharmaceuticals and nutraceuticals. With a focus on drug product development and manufacturing, PolyGen offers a wide range of products and services. For over 25 years, PolyGen has been a key player in America's generic pharmaceutical industry, offering FDA-approved generic versions of brand medications at affordable prices.

These generic drugs have the same active ingredients and strength as their brand-name counterparts, ensuring the same quality of care for consumers. As a rapidly growing company, PolyGen Pharmaceuticals owns a robust pipeline of multi-source and high barrier products, constantly introducing new generics to the market. Their state-of-the-art 30,000 square feet facility in Edgewood, New York, features cGMP manufacturing areas, R&D suites, and a quality control laboratory, ensuring the highest standards of production.

PolyGen Pharmaceuticals' vision is to become a top pharmaceutical company by developing a diverse portfolio of quality generic products. Their mission is to provide safe, effective, and high-quality products, driven by the commitment, training, and constant improvement of each member of their organization